Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001835:Body Weight; D002302:Cardiac Output; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D007097:Imines / Q000627:therapeutic use; D007668:Kidney / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000627:therapeutic use*; D011433:Propranolol / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012083:Renin / Q000378:metabolism; D012964:Sodium / Q000378:metabolism
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D007097:Imines; D010880:Piperidines; D011743:Pyrimidines; D006852:Hydrochlorothiazide; D006830:Hydralazine; D005665:Furosemide; D012964:Sodium; D011433:Propranolol; D012083:Renin